sulfonylurea atp-sensit K+ channel cellular K+ loss hypoxia ischemia metabol inhibit mammalian ventricl sulfonylurea deriv select blocker atp-sensit K+ katp channel abil cellular K+ loss shorten action potenti durat ischemia hypoxia intact heart modest efficaci katp channel excis membran patch isol perfus rabbit interventricular septum increas unidirect K+ efflux shorten action potenti durat substrate-fre hypoxia glibenclamid high concentr microm hypoxia glucos present glibenclamid effect K+ loss total global ischemia minut microm glibenclamid mM shorten action potenti durat K+ accumul maximum isol patch-clamp guinea pig ventricular myocyt whole-cel atp-sensit K+ current exposur metabol inhibitor glibenclamid microm tolbutamid mM effect whole-cel atp-sensit K+ current maximum block adp patch electrod solut inside-out membran patch myocyt glibenclamid unitari current katp channel Kd microm hill coeffici absenc adp cytosol membran surfac block incomplet microm adp free present adp similar effect block katp channel tolbutamid find free cytosol adp microm rang earli myocardi ischemia hypoxia limit efficaci sulfonylurea ischem hypox cellular K+ loss condit 